Author:
Perrotta Fabio,Kerr Keith M.,Navani Neal
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference6 articles.
1. Consistency analysis of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer: a retrospective study;Luo;J Cancer,2020
2. Inter-tumor heterogeneity of PD-L1 expression in non-small cell lung cancer;Saito;J Thorac Dis,2019
3. The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: a retrospective study;Verocq;Oncol Lett,2020
4. PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of Blueprint Phase 2 Project;Tsao;J Thorac Oncol,2018
5. Programmed death-ligand 1 heterogeneity and its impact on benefit from immune checkpoint inhibitors in NSCLC;Hong;J Thorac Oncol,2020